Gene Expression Profiling in Human Gastric Intestinal Metaplasia Mucosa and Duodenal Mucosa

Gastric Intestinal Metaplasia Clinical Trial

Official title:

Gene Expression Profiling in Human Gastric Intestinal Metaplasia Mucosa and Duodenal Mucosa.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02846688
• Other study ID #: 2015SDU-QILU-G05
• Status: Completed
• Phase: N/A
• First received: July 22, 2016
• Last updated: July 25, 2016
• Start date: September 2014
• Est. completion date: July 2015

Study information

• Verified date: July 2016
• Source: Shandong University
• Contact: n/a
• Is FDA regulated: No
• Health authority: China: Ministry of Health
• Study type: Observational

Clinical Trial Summary

To analyze the genome pattern in human gastric Intestinal Metaplasia Mucosa and duodenal Mucosa.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 15
• Est. completion date: July 2015
• Est. primary completion date: July 2015
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• Patients scheduled for gastroendoscopy examination

Exclusion Criteria:

• Esophageal, gastric or duodenal cancer or other malignancy History of upper GI tract surgery Coagulopathy or bleeding disorders Allergy to fluorescein sodium

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

• Duodenum
• Gastric Intestinal Metaplasia
• Gene Expression Profiling
• Metaplasia

Locations

Country	Name	City	State
China	Department of Gastroenterology, Qilu Hospital, Shandong University	Jinan	Shandong

Sponsors (1)

Lead Sponsor	Collaborator
Shandong University

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Gene Expression Profiling in Human Gastric Intestinal Metaplasia Mucosa and Duodenal Mucosa		6 months	No